GOSS
Companies
NASDAQ
Gossamer Bio Inc.
Health Care
$1.29
+$0.39 (+42.54%)
Price Chart
Overview
About GOSS
gossamer bio is a san diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. founded by the former receptos executive team, gossamer bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
Market Cap
$124.1M
Volume
2.1M
Avg. Volume
2.1M
P/E Ratio
-1.2615943
Dividend Yield
0.00%
Employees
164.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.45
High Correlation
Volatility
High (0.86)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, GOSS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$124.1M
Volume2.1M
P/E Ratio-1.26
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 14, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025